Miralax
NDC Package 11523-7234-4
Package Information
Miralax is do not take more than directed unless advised by your doctorthe bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line (white section in cap)adults and children 17 years of age and older: fill to top of white section in cap which is marked to indicate the correct dose (17 g)stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drinkuse once a dayuse no more than 7 dayschildren 16 years of age or under: ask a doctor. Marketed by Bayer Healthcare Llc., this product is identified by NDC 11523-7234 and is authorized under FDA application NDA022015.
Identification & Billing
- RxCUI: 876193 - polyethylene glycol 3350 17 GM Powder for Oral Solution
- RxCUI: 876193 - polyethylene glycol 3350 17000 MG Powder for Oral Solution
- RxCUI: 876195 - MiraLAX 17 GM Powder for Oral Solution
- RxCUI: 876195 - polyethylene glycol 3350 17000 MG Powder for Oral Solution [Miralax]
- RxCUI: 876195 - Miralax 17 GM Powder for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11523 - Bayer Healthcare Llc.
- 11523-7234 - Miralax
- 11523-7234-4 - 510 g in 1 BOTTLE, PLASTIC
- 11523-7234 - Miralax
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (11523-7234). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11523-7234-4 identifies a specific commercial package of 510 g in 1 bottle, plastic of Miralax, labeled by Bayer Healthcare Llc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bayer Healthcare Llc. on February 01, 2007. The current certification is valid through December 31, 2027.
How is this Bayer Healthcare Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11523723404. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 510 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.